Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms

COVID-19 disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), started in December 2019 in Wuhan, China, and quickly became the global pandemic. The high spread rate, relatively high mortality rate, and the lack of specific medicine have led researchers and clinicians w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaffash Farkhad, Najmeh, Mahmoudi, Ali, Mahdipour, Elahe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938276/
https://www.ncbi.nlm.nih.gov/pubmed/35340407
http://dx.doi.org/10.1016/j.reth.2022.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938276/
https://www.ncbi.nlm.nih.gov/pubmed/35340407
http://dx.doi.org/10.1016/j.reth.2022.03.006

Ejemplares similares